title: [Pulmonary hypertension associated with left heart disease: recommendations of the Cologne Consensus Conference 2016].
abstract: The 2015 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension are also valid for Germany. While the guidelines contain detailed recommendations regarding pulmonary arterial hypertension (PAH), they contain only a relatively short paragraph on other, much more common forms of PH such as PH due to left heart disease. Despite the lack of data, targeted PAH treatments are increasingly being used for PH associated with left heart disease. This development is of concern because of limited ressources and the need to base treatments on scientific evidence. On the other hand, PH is a frequent problem that is highly relevant for morbidity and mortality in patients with left heart disease, representing an unmet need of targeted PH therapies. It that sense, the practical implementation of the European Guidelines in Germany requires the consideration of several specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, several working groups were initiated, one of which was specifically dedicated to PH associated with left heart disease. This article summarizes the results and recommendations of this working group.
authors.forename: S
authors.initials: S
authors.lastname: Rosenkranz
authors.forename: I M
authors.initials: IM
authors.lastname: Lang
authors.forename: R
authors.initials: R
authors.lastname: Blindt
authors.forename: D
authors.initials: D
authors.lastname: Bonderman
authors.forename: L
authors.initials: L
authors.lastname: Bruch
authors.forename: G P
authors.initials: GP
authors.lastname: Diller
authors.forename: R
authors.initials: R
authors.lastname: Felgendreher
authors.forename: C
authors.initials: C
authors.lastname: Gerges
authors.forename: W
authors.initials: W
authors.lastname: Hohenforst-Schmidt
authors.forename: S
authors.initials: S
authors.lastname: Holt
authors.forename: C
authors.initials: C
authors.lastname: Jung
authors.forename: I
authors.initials: I
authors.lastname: Kindermann
authors.forename: T
authors.initials: T
authors.lastname: Kramer
authors.forename: W M
authors.initials: WM
authors.lastname: Kübler
authors.forename: V
authors.initials: V
authors.lastname: Mitrovic
authors.forename: A
authors.initials: A
authors.lastname: Riedel
authors.forename: A
authors.initials: A
authors.lastname: Rieth
authors.forename: A
authors.initials: A
authors.lastname: Schmeisser
authors.forename: R
authors.initials: R
authors.lastname: Wachter
authors.forename: J
authors.initials: J
authors.lastname: Weil
authors.forename: C
authors.initials: C
authors.lastname: Opitz
mesh_terms: D002309:Cardiology / Q000592:standards*; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D017410:Practice Guidelines as Topic; D015272:Pulmonary Medicine / Q000592:standards*; D016896:Treatment Outcome; D018497:Ventricular Dysfunction, Right / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*